{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:50:23Z","timestamp":1761897023269,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002873","name":"Chulalongkorn University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002873","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","geriatriconcology.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Geriatric Oncology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.jgo.2019.03.016","type":"journal-article","created":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T08:23:12Z","timestamp":1553934192000},"page":"62-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Characteristics, treatment patterns, prognostic determinants and outcome of peripheral T cell lymphoma and natural killer\/T cell non-Hodgkin Lymphoma in older patients: The result of the nationwide multi-institutional registry Thai Lymphoma Study Group"],"prefix":"10.1016","volume":"11","author":[{"given":"Kitsada","family":"Wudhikarn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Udomsak","family":"Bunworasate","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakrawadee","family":"Julamanee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnuparp","family":"Lekhakula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2101-595X","authenticated-orcid":false,"given":"Supachai","family":"Ekwattanakit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Archrob","family":"Khuhapinant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suporn","family":"Chuncharunee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pimjai","family":"Niparuck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tontanai","family":"Numbenjapon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kannadit","family":"Prayongratana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nonglak","family":"Kanitsap","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Somchai","family":"Wongkhantee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nisa","family":"Makruasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peerapon","family":"Wong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2223-5711","authenticated-orcid":false,"given":"Lalita","family":"Norasetthada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weerasak","family":"Nawarawong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chittima","family":"Sirijerachai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kanchana","family":"Chansung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tawatchai","family":"Suwanban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pannee","family":"Praditsuktavorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanin","family":"Intragumtornchai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"25","key":"10.1016\/j.jgo.2019.03.016_bb0005","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1200\/JCO.2008.16.4558","article-title":"International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes","volume":"26","author":"Vose","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jgo.2019.03.016_bb0010","series-title":"Epidemiology of Lymphoid Malignancy in Asia","volume":"I","author":"Mozaheb","year":"2012"},{"issue":"6","key":"10.1016\/j.jgo.2019.03.016_bb0015","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1007\/s11899-016-0353-y","article-title":"T-cell lymphoma epidemiology: the known and unknown","volume":"11","author":"Phan","year":"2016","journal-title":"Curr Hematol Malig Rep"},{"issue":"3","key":"10.1016\/j.jgo.2019.03.016_bb0020","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s12185-014-1520-3","article-title":"Peripheral T cell lymphoma in Asia","volume":"99","author":"Park","year":"2014","journal-title":"Int J Hematol"},{"issue":"18","key":"10.1016\/j.jgo.2019.03.016_bb0025","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1182\/blood-2010-02-270785","article-title":"Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group","volume":"116","author":"Schmitz","year":"2010","journal-title":"Blood."},{"issue":"7","key":"10.1016\/j.jgo.2019.03.016_bb0030","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.ctrv.2013.01.007","article-title":"Barriers to inclusion of older adults in randomised controlled clinical trials on Non-Hodgkin's lymphoma: a systematic review","volume":"39","author":"Bellera","year":"2013","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"10.1016\/j.jgo.2019.03.016_bb0035","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/hon.2153","article-title":"Evaluation of clinical trial eligibility and prognostic indices in a population-based cohort of systemic peripheral T-cell lymphomas from the Danish Lymphoma Registry","volume":"33","author":"Pedersen","year":"2015","journal-title":"Hematol Oncol"},{"issue":"Suppl. 5","key":"10.1016\/j.jgo.2019.03.016_bb0040","doi-asserted-by":"crossref","first-page":"v108","DOI":"10.1093\/annonc\/mdv201","article-title":"Peripheral T-cell lymphomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"26","author":"d'Amore","year":"2015","journal-title":"Ann Oncol"},{"issue":"21","key":"10.1016\/j.jgo.2019.03.016_bb0045","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1182\/blood.V118.21.2064.2064","article-title":"A nationwide prospective multicenter study of clinical features and outcomes of Non-Hodgkin Lymphoma in Thailand: an analysis of 939 cases","volume":"118","author":"Bunworasate","year":"2011","journal-title":"Blood."},{"issue":"1","key":"10.1016\/j.jgo.2019.03.016_bb0050","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/10428194.2012.698739","article-title":"Inferior progression-free survival for Thai patients with diffuse large B-cell lymphoma treated under Universal Coverage Scheme: the impact of rituximab inaccessability","volume":"54","author":"Intragumtornchai","year":"2013","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"10.1016\/j.jgo.2019.03.016_bb0055","doi-asserted-by":"crossref","first-page":"219","DOI":"10.2307\/2534009","article-title":"Prediction of cumulative incidence function under the proportional hazards model","volume":"54","author":"Cheng","year":"1998","journal-title":"Biometrics."},{"issue":"6","key":"10.1016\/j.jgo.2019.03.016_bb0060","first-page":"443","article-title":"2016 US lymphoid malignancy statistics by World Health Organization subtypes","volume":"66","author":"Teras","year":"2016","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"10.1016\/j.jgo.2019.03.016_bb0065","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/hon.2392","article-title":"Non-Hodgkin lymphoma in South East Asia: an analysis of the histopathology, clinical features, and survival from Thailand","volume":"36","author":"Intragumtornchai","year":"2018","journal-title":"Hematol Oncol"},{"issue":"4","key":"10.1016\/j.jgo.2019.03.016_bb0070","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s00277-016-2597-y","article-title":"Peripheral T cell lymphomas in elderly patients: a retrospective analysis from the Hematology Association of South East Korea (HASEK)","volume":"95","author":"Jo","year":"2016","journal-title":"Ann Hematol"},{"issue":"23","key":"10.1016\/j.jgo.2019.03.016_bb0075","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1182\/blood.V126.23.3953.3953","article-title":"Efficacy and safety of dose attenuated CHOP chemotherapy for peripheral T-cell lymphoma in elderly patients","volume":"126","author":"Choi","year":"2015","journal-title":"Blood."},{"key":"10.1016\/j.jgo.2019.03.016_bb0080","first-page":"1795","article-title":"Comorbidity as an independent prognostic factor in elderly patients with peripheral T-cell lymphoma","volume":"9","author":"Zhao","year":"2016","journal-title":"Onco Targets Ther"},{"issue":"22","key":"10.1016\/j.jgo.2019.03.016_bb0085","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.1182\/blood.V128.22.3000.3000","article-title":"Population-based analysis of elderly patients (>70 Years) with peripheral T-CELL lymphoma: a results from Czech Lymphoma Study Group (CLSG) registry","volume":"128","author":"Janikova","year":"2016","journal-title":"Blood."},{"issue":"1","key":"10.1016\/j.jgo.2019.03.016_bb0090","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/hon.2428","article-title":"Impact of comorbidity on survival in peripheral T-cell lymphomas: a Swedish Lymphoma Registry study","volume":"36","author":"Ellin","year":"2018","journal-title":"Hematol Oncol"},{"issue":"1","key":"10.1016\/j.jgo.2019.03.016_bb0095","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3960\/jslrt.56.43","article-title":"Retrospective analysis of treatment outcomes and geriatric assessment in elderly malignant lymphoma patients","volume":"56","author":"Naito","year":"2016","journal-title":"J Clin Exp Hematop"},{"issue":"10","key":"10.1016\/j.jgo.2019.03.016_bb0100","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1093\/annonc\/mdt282","article-title":"Lymphoma occurring in patients over 90 years of age: characteristics, outcomes, and prognostic factors. A retrospective analysis of 234 cases from the LYSA","volume":"24","author":"Trebouet","year":"2013","journal-title":"Ann Oncol"},{"issue":"24","key":"10.1016\/j.jgo.2019.03.016_bb0105","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1182\/bloodadvances.2017010819","article-title":"Redefining the role of etoposide in first-line treatment of peripheral T-cell lymphoma","volume":"1","author":"Kim","year":"2017","journal-title":"Blood Advances"},{"key":"10.1016\/j.jgo.2019.03.016_bb0110","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jgo.2010.08.006","article-title":"Diffuse large B-cell and peripheral T-cell non-Hodgkin's lymphoma in the frail elderly: a phase II EORTC trial with a progressive and cautious treatment emphasizing geriatric assessment","volume":"2","author":"Soubeyran","year":"2011","journal-title":"J Geriat Oncol"},{"issue":"5","key":"10.1016\/j.jgo.2019.03.016_bb0115","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1634\/theoncologist.2016-0260","article-title":"A host-dependent prognostic model for elderly patients with diffuse large B-cell lymphoma","volume":"22","author":"Miura","year":"2017","journal-title":"Oncologist"},{"year":"2011","series-title":"A nationwide prospective multicenter study of clinical features and outcomes of non-Hodgkin Lymphoma in Thailand: an analysis of 939 Cases","key":"10.1016\/j.jgo.2019.03.016_bb0120"},{"issue":"10","key":"10.1016\/j.jgo.2019.03.016_bb0125","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1080\/10428194.2017.1295143","article-title":"Romidepsin is effective and well tolerated in older patients with peripheral T-cell lymphoma: analysis of two phase II trials","volume":"58","author":"Shustov","year":"2017","journal-title":"Leuk Lymphoma"}],"container-title":["Journal of Geriatric Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406818303631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879406818303631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T09:51:05Z","timestamp":1761817865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879406818303631"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S1879406818303631"],"URL":"https:\/\/doi.org\/10.1016\/j.jgo.2019.03.016","relation":{},"ISSN":["1879-4068"],"issn-type":[{"type":"print","value":"1879-4068"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characteristics, treatment patterns, prognostic determinants and outcome of peripheral T cell lymphoma and natural killer\/T cell non-Hodgkin Lymphoma in older patients: The result of the nationwide multi-institutional registry Thai Lymphoma Study Group","name":"articletitle","label":"Article Title"},{"value":"Journal of Geriatric Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jgo.2019.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}